Our goal is set the standard for blood function diagnostics in Sickle Cell Disease and a wide range of bleeding and clotting disorders.
Patrick Hines, MD PhD
Founder & Chief Executive Officer
Assistant Professor of Pediatric Critical Care Medicine and Associate in the Department of Physiology, Wayne State University School of Medicine., Children’s Hospital of Michigan. Previous business and technology consultant for Quantum Genomics, University of North Carolina at Chapel Hill – based startup specializing in models of human diseases. Past chairman of the board of directors for the SNMA.
Jennell White, PhD
Co-inventor of microfluidic flow-based clinical assays as a post-doctoral fellow in the Hines lab at Wayne State University School of Medicine. With Over 10 years of both basic science and clinical laboratory experience, Dr. White Co-directs bioassay innovation.
Xiufeng Gao, MD
Co-inventor of microfluidic flow-based clinical assays in Hines lab at Wayne State University School of Medicine. With over 23 years of senior level research experience in toxicology, pharmacology, and blood-based assay development, Dr. Gao Co-directs bioassay innovation.
John Cunningham, MBA/MS
Chief Operating Officer
An experienced startup executive. Previously served as Mentor in Residence, Wayne State University Office of Technology Transfer, Managing Member Innoventures, CEO Meadowlark Energy, CEO Rapid Biosense.
Ke Liu, PhD
Previously Senior Scientist, nanoRETE, Inc. Developed, validated, and optimized nanoRETE’s proprietary nanoparticle electrochemical-based biosensors for food pathogen and tuberculosis (TB) biomarker detection. Directs innovation efforts in bioassay analysis.
Current student at Wayne State University and Student Research Assistant in Hines lab at Wayne State University School of Medicine since 2013. Semi-finalist in the Accelerate Michigan Innovation Competition presenting on behalf of Functional Fluidics in 2013
Functional Fluidics Presented At The Foundation for Sickle Cell Disease Research, April 28-30, Fort Lauderdale, FL Dr. Patrick Hines chaired an education session on biomarkers and surrogate endpoints at the Foundation for Sickle Cell Disease Research (FSCDR) meeting...read more
ANGELA G. KING December 12, 2016 It’s no bigger than a dime, thus inspiring the occasional “lab-on-a-chip” reference, but a tiny blood-analyzing device created by a multidisciplinary team of researchers helmed by the president of Carnegie Mellon University could prove...read more
The Detroit chapter of the Sickle Cell Disease Association of America invited Dr. Hines to speak at an event sponsored by Pfizer on November 30th, 2016. This event was attending primarily by SCD patients and their families. The goal was to teach patients about...read more
Dr. Hines was invited to speak at Bio Arbor on June 16th with a panel of other Life Sciences CEO’s. This special event featured advanced life science technology companies from Michigan presenting 8-minute pitches outlining their products, their technology and...read more